Elevated CD47 expression in some cancers is associated with decreased survival and limited clearance by phagocytes expressing the CD47 counterreceptor SIRPα. In contrast …
L Wu, GT Yu, WW Deng, L Mao, LL Yang, SR Ma… - …, 2018 - Taylor & Francis
Head and neck squamous cell carcinoma (HNSCC) is considered as an immunosuppressive disease, with impaired tumor-infiltrating T lymphocytes and increased …
F Kong, F Gao, H Li, H Liu, Y Zhang, R Zheng… - Clinical and …, 2016 - Springer
The relationship between the immune system and cancer growth and aggravation has been discussed over a century. A number of molecules have been shown to participate in this …
M Tan, L Zhu, H Zhuang, Y Hao, S Gao… - American journal of …, 2015 - ncbi.nlm.nih.gov
CD47 is a membrane receptor that belongs to the immunoglobulin superfamily and plays an important role in the mechanisms of tumor immune escape. CD47 participates in tumor …
K Sakakura, H Takahashi, K Kaira, M Toyoda… - Laboratory …, 2016 - Elsevier
Tumor-associated macrophages (TAM) have been classified into an immunostimulatory M1 subset against microbes and malignancies, and an immunoregulatory M2 subset that …
U Johansson, K Higginbottom… - Scandinavian journal of …, 2004 - Wiley Online Library
CD47 is a versatile cell‐surface molecule expressed on nearly all haematopoietic cells. In its capacity as a thrombospondin‐1 (TSP‐1) receptor, CD47 has recently been shown to …
T Sudo, Y Takahashi, G Sawada, R Uchi… - Oncology …, 2017 - spandidos-publications.com
Abstract Integrin-associated protein (CD47) is ubiquitously expressed on the surface of cells and functions as an identifier of self. In blood cancer, tumor cells expressing CD47 evade …
SB Willingham, JP Volkmer… - Proceedings of the …, 2012 - National Acad Sciences
CD47, a “don't eat me” signal for phagocytic cells, is expressed on the surface of all human solid tumor cells. Analysis of patient tumor and matched adjacent normal (nontumor) tissue …
The treatment of breast cancer largely depends on the utilization of immunogenic chemotherapeutics, which, as a common leitmotif, stimulate the exposure of calreticulin …